Pharmaids Pharmaceuticals Announcements
Certificate under Regulation 74(5) of the SEBI (Depositaries and Participants) Regulations, 2018 for the quarter ended March 31, 2026.
07 Apr, 2026 | 02:22pm • Source: BSE
Sale of entire shareholding held by Adita Bio Sys Private Limited (material subsidiary of the Company) in Siri Labvivo Diet Private Limited, a step-down subsidiary,...
27 Mar, 2026 | 09:41pm • Source: BSE
Intimation of Trading Window Closure pursuant to declaration of Audited Financial Results for the quarter and Year ended March 31, 2026.
25 Mar, 2026 | 05:49pm • Source: BSE
Corrigendum to the newspaper publication dated February 14, 2026, regarding unaudited financial results (Consolidated and Standalone) for the quarter and nine months ended December 31,...
15 Feb, 2026 | 01:20pm • Source: BSE
Pharmaids Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and...
09 Feb, 2026 | 12:18pm • Source: BSE
Report on shares re-lodged for transfer cum Demat of Physical shares.
16 Jan, 2026 | 03:53pm • Source: BSE
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2025.
12 Jan, 2026 | 04:01pm • Source: BSE
Intimation regarding completion of term of Independent Director of Mr. Mopperthy Sudheer
05 Jan, 2026 | 06:03pm • Source: BSE
Outcome of the circular resolution dated January 05, 2026 for the reconstitution of the Audit and Nomination and Remuneration Committee of the Board.
05 Jan, 2026 | 05:13pm • Source: BSE
This is to inform you that shareholders of the company have approved the appointment of Dr. Yogananda Moolemath (DIN: 02870387) as an Independent Director of...
02 Jan, 2026 | 03:13pm • Source: BSE
Please find enclosed scrutinizer''s report along with the proceedings of the meeting held by way of postal ballot through remote e-voting process.
02 Jan, 2026 | 02:39pm • Source: BSE
Intimation of Closure of Trading Window.
30 Dec, 2025 | 01:03pm • Source: BSE
Report on re-lodgment of requests for transfer of Physical shares
12 Dec, 2025 | 03:25pm • Source: BSE
Enclosed disclosure under Regulation 30 (LODR).
10 Dec, 2025 | 10:02pm • Source: BSE
Newspaper publication of Postal Ballot Notice
30 Nov, 2025 | 08:15pm • Source: BSE
Intimation of Postal Ballot notice
29 Nov, 2025 | 03:55pm • Source: BSE
Outcome of the Circular resolution dated 28th November 2025 for appointment of Dr.Yoganand Moolemath (DIN: 02870387) as Independent Director, subject approval of shareholders and other...
28 Nov, 2025 | 05:23pm • Source: BSE
Report on Re-lodgement of requests for transfer of Physical shares.
12 Nov, 2025 | 12:38pm • Source: BSE
Unaudited financial results for the quarter and half year ended September 30, 2025.
11 Nov, 2025 | 06:30pm • Source: BSE
Outcome of the Board Meeting held on Tuesday, November 11, 2025, i.e, today, to consider and approve the un-audited financial results for the quarter...
11 Nov, 2025 | 06:28pm • Source: BSE